Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized treatment of 95 poorly differentiated thyroid cancer/anaplastic thyroid cancer in 2019-2023.

European thyroid journal - 1 Dec 2025

Huang Nai-Si, Chen Jia-Ying, Wei Wen-Jun, Hu Jia-Qian, Wang Yun-Jun, Liu Wan-Lin, Guan Qing, Sun Tuan-Qi, Wang Yu-Long, Xiang Jun, Ji Qing-Hai, Ji Dong-Mei, Wang Yu

Abstract excerpt

Background: Poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC) are both rare and aggressive thyroid cancers. Advances in targeted therapy and immunotherapy have changed treatment strategies and improved prognosis in these patients. Methods: This single-center cohort study included patients diagnosed with locally advanced or metastatic PDTC/ATC at Fudan University Shanghai Cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precision Medicine

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Share to Telomerase

Share to Thyroid Carcinoma, Anaplastic

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 41104970
DOI: 10.1530/ETJ-24-0371
PMCID: PMC12598928

Genes

BRAF
TERT
TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized treatment of 95 poorly differentiated thyroid cancer/anaplastic thyroid cancer in 2019-2023.PMID 41104970Read ↗

Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next‐generation sequencingSemantic proximity Read ↗

Anaplastic thyroid cancer:Improved understanding of what remains a deadly disease.Semantic proximity Read ↗

Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma.Semantic proximity Read ↗

Updates on the Management of Thyroid Cancer.Semantic proximity Read ↗

Real-world outcomes and prognostic factors in anaplastic thyroid cancer: evidence from the REGETNE-Thyroid cohort.Semantic proximity Read ↗

Untitled literature recordSemantic proximity Read ↗

Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New DrugsSemantic proximity Read ↗

Personalized Therapy in Patients With Anaplastic Thyroid Cancer: Targeting Genetic and Epigenetic AlterationsSemantic proximity Read ↗

Recent Improvements in Genomic and Transcriptomic Understanding of Anaplastic and Poorly Differentiated Thyroid Cancers.Semantic proximity Read ↗

Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.Semantic proximity Read ↗

Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approachesSemantic proximity Read ↗

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.